Monotherapy Results From an Ongoing Phase 1a Dose Escalation Study of NDI-101150, a Highly Selective Oral Hematopoietic Progenitor Kinase 1 (HPK1) Inhibitor
NDI-101150
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Monotherapy Results From an Ongoing Phase 1a Dose Escalation Study of NDI-101150, a Highly Selective Oral Hematopoietic Progenitor Kinase 1 (HPK1) Inhibitor ### Output: NDI-101150